HK1143595A1 - Proteasome inhibitors - Google Patents

Proteasome inhibitors

Info

Publication number
HK1143595A1
HK1143595A1 HK10110167.4A HK10110167A HK1143595A1 HK 1143595 A1 HK1143595 A1 HK 1143595A1 HK 10110167 A HK10110167 A HK 10110167A HK 1143595 A1 HK1143595 A1 HK 1143595A1
Authority
HK
Hong Kong
Prior art keywords
proteasome inhibitors
proteasome
inhibitors
Prior art date
Application number
HK10110167.4A
Other languages
English (en)
Inventor
Edward J Olhava
Miheala D Danca
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38691782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1143595(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of HK1143595A1 publication Critical patent/HK1143595A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10110167.4A 2007-08-06 2010-10-28 Proteasome inhibitors HK1143595A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/017440 WO2009020448A1 (en) 2007-08-06 2007-08-06 Proteasome inhibitors

Publications (1)

Publication Number Publication Date
HK1143595A1 true HK1143595A1 (en) 2011-01-07

Family

ID=38691782

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10110167.4A HK1143595A1 (en) 2007-08-06 2010-10-28 Proteasome inhibitors
HK13110199.3A HK1182924A1 (zh) 2007-08-06 2013-09-02 蛋白酶體抑制劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK13110199.3A HK1182924A1 (zh) 2007-08-06 2013-09-02 蛋白酶體抑制劑

Country Status (33)

Country Link
EP (3) EP2527347A1 (ru)
JP (1) JP5261488B2 (ru)
KR (6) KR20140042932A (ru)
CN (1) CN101772507B (ru)
AU (1) AU2007357338B2 (ru)
BR (1) BRPI0721905B8 (ru)
CA (1) CA2695082C (ru)
CY (2) CY1113386T1 (ru)
DK (1) DK2178888T3 (ru)
EA (1) EA028622B1 (ru)
EC (1) ECSP10010015A (ru)
ES (1) ES2390606T3 (ru)
FR (1) FR17C1011I2 (ru)
GE (1) GEP20125599B (ru)
HK (2) HK1143595A1 (ru)
HR (1) HRP20120745T1 (ru)
HU (1) HUS1700018I1 (ru)
IL (4) IL203641A (ru)
LT (1) LTC2178888I2 (ru)
LU (1) LUC00013I2 (ru)
MY (1) MY161991A (ru)
NL (1) NL300871I2 (ru)
NZ (1) NZ582693A (ru)
PH (1) PH12014500053B1 (ru)
PL (1) PL2178888T3 (ru)
PT (1) PT2178888E (ru)
RS (1) RS52435B (ru)
SG (1) SG10201508712QA (ru)
SI (1) SI2178888T1 (ru)
TN (1) TN2010000060A1 (ru)
UA (1) UA97536C2 (ru)
WO (1) WO2009020448A1 (ru)
ZA (1) ZA201000348B (ru)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576206B2 (en) 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7468383B2 (en) 2005-02-11 2008-12-23 Cephalon, Inc. Proteasome inhibitors and methods of using the same
PT1948678E (pt) 2005-11-09 2013-07-16 Onyx Therapeutics Inc Compostos para inibição de enzimas
CA2657213C (en) 2006-06-19 2017-01-03 Proteolix, Inc. Peptide epoxyketones for proteasome inhibition
US7442830B1 (en) 2007-08-06 2008-10-28 Millenium Pharmaceuticals, Inc. Proteasome inhibitors
ES2578905T5 (es) 2007-10-04 2020-03-18 Onyx Therapeutics Inc Inhibidores de proteasa epoxi cetona peptídicos cristalinos y la síntesis de ceto-epóxidos de aminoácidos
GEP201706703B (en) 2008-06-17 2017-07-25 Millennium Pharmaceuticals Inc (A Delaware Corporation) Boronate ester compounds and pharmaceutical compositions thereof
AR075090A1 (es) 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
AP2011005690A0 (en) 2008-10-21 2011-06-30 Onyx Therapeutics Inc Combination therapy with peptide epoxyketones.
AR075899A1 (es) 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
US8853147B2 (en) 2009-11-13 2014-10-07 Onyx Therapeutics, Inc. Use of peptide epoxyketones for metastasis suppression
CN102725300B (zh) 2009-12-22 2015-03-11 赛福伦公司 蛋白酶体抑制剂及其制备、纯化、和应用的方法
MA34133B1 (fr) 2010-03-01 2013-04-03 Onyx Therapeutics Inc Composes pour inhibiteurs de l'immunoproteasome
US8513218B2 (en) 2010-03-31 2013-08-20 Millennium Pharmaceuticals, Inc. Derivatives of 1-amino-2-cyclopropylethylboronic acid
WO2012177835A1 (en) * 2011-06-22 2012-12-27 Cephalon, Inc. Proteasome inhibitors and processes for their preparation, purification and use
HUE060305T2 (hu) * 2011-08-30 2023-02-28 Tufts College FAP-aktivált proteaszóma inhibitorok a szolid tumorok kezelésére
SG11201403254QA (en) * 2011-12-22 2014-07-30 Ares Trading Sa Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
CA2862320A1 (en) * 2012-01-24 2013-08-01 Millennium Pharmaceuticals, Inc. Method of treatment of nasopharyngeal cancer
US20160008382A1 (en) * 2012-01-24 2016-01-14 Millennium Pharmaceuticals, Inc. Methods of treatment of cancer
US9309283B2 (en) 2012-07-09 2016-04-12 Onyx Therapeutics, Inc. Prodrugs of peptide epoxy ketone protease inhibitors
CN109180780B (zh) * 2012-07-26 2022-03-18 圣特莱国际公司 多肽环氧酮化合物
JP2013006855A (ja) * 2012-09-03 2013-01-10 Millennium Pharmaceuticals Inc プロテアソーム阻害剤
ES2615744T3 (es) * 2012-12-03 2017-06-08 F. Hoffmann-La Roche Ag Compuestos de ácido triazol-borónico sustituidos
EA201690686A1 (ru) * 2013-10-03 2016-08-31 Милленниум Фармасьютикалз, Инк. Способ профилактики или лечения системной красной волчанки и/или волчаночного нефрита
MA39964A (fr) 2014-05-20 2015-11-26 Millennium Pharm Inc Inhibiteurs du protéasome contenant du bore destinés à être utilisés après une thérapie contre le cancer primaire
EP3808349B1 (en) 2014-08-07 2022-10-05 Mayo Foundation for Medical Education and Research Compounds and methods for treating cancer
MA41555A (fr) * 2015-02-17 2017-12-26 Millennium Pharm Inc Polythérapie pour le traitement du cancer
US10144761B2 (en) 2015-06-19 2018-12-04 Hanlin Scientific Inc. Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis
CN106608883A (zh) * 2015-10-21 2017-05-03 北京大学 蛋白酶体抑制剂mln9708的合成方法
WO2017198194A1 (zh) * 2016-05-19 2017-11-23 成都奥璟生物科技有限公司 一种硼酸和硼酸酯类化合物及其应用
CN106008572B (zh) * 2016-05-23 2018-08-17 成都千禧莱医药科技有限公司 一类二肽硼酸化合物及制备方法和用途
KR102595723B1 (ko) 2016-06-21 2023-10-27 오리온 옵탈몰로지 엘엘씨 헤테로시클릭 프롤린아미드 유도체
JP7164521B2 (ja) 2016-06-21 2022-11-01 オリオン・オフサルモロジー・エルエルシー 炭素環式プロリンアミド誘導体
US10995103B2 (en) 2016-07-25 2021-05-04 Shenzhen Targetrx, Inc. Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
TW201831191A (zh) * 2017-01-23 2018-09-01 大陸商成都奥璟生物科技有限公司 一種新的硼酸衍生物及其藥物組合物
WO2018160717A1 (en) 2017-02-28 2018-09-07 Mayo Foundation For Medical Education And Research Compounds and methods for treating cancer
CN108794516A (zh) * 2017-04-26 2018-11-13 上海时莱生物技术有限公司 硼酸和硼酸酯类化合物及其制备方法和用途
CN109305980B (zh) * 2017-07-28 2022-10-11 成都奥璟生物科技有限公司 一种硼酸酯化合物、其合成方法及其用途
EP3672978B1 (en) 2017-08-25 2021-10-06 Synthon B.V. Process for making ixazomib and its intermediates
JP2018024694A (ja) * 2017-10-03 2018-02-15 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． プロテアソーム阻害剤
US11243207B2 (en) 2018-03-29 2022-02-08 Mayo Foundation For Medical Education And Research Assessing and treating cancer
CN110903310B (zh) * 2018-09-14 2022-11-22 成都奥璟生物科技有限公司 一种硼酸酯类药物及其用途
CN110357787A (zh) * 2019-08-02 2019-10-22 苏州艾和医药科技有限公司 依沙佐米合成工艺研究
US20220362268A1 (en) * 2019-10-07 2022-11-17 Cornell University Antimicrobial and antiviral effects of c2-c7 alkyl boronic acids
CN110950897B (zh) * 2019-12-12 2021-05-28 山东大学 一种组蛋白去乙酰化酶、蛋白酶体双靶点抑制剂及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US5250720A (en) 1987-06-05 1993-10-05 The Dupont Merck Pharmaceutical Company Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases
US5242904A (en) 1987-06-05 1993-09-07 The Dupont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0315574A3 (de) 1987-11-05 1990-08-22 Hoechst Aktiengesellschaft Renin-Inhibitoren
US5106948A (en) 1988-05-27 1992-04-21 Mao Foundation For Medical Education And Research Cytotoxic boronic acid peptide analogs
US6083903A (en) * 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
EP1355910B1 (en) * 2001-01-25 2011-03-09 The United States of America, represented by the Secretary, Department of Health and Human Services Formulation of boronic acid compounds
US6933290B2 (en) 2001-05-30 2005-08-23 Novartis Ag 2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives
US7576206B2 (en) * 2003-08-14 2009-08-18 Cephalon, Inc. Proteasome inhibitors and methods of using the same
US7223745B2 (en) 2003-08-14 2007-05-29 Cephalon, Inc. Proteasome inhibitors and methods of using the same
UA88771C2 (ru) * 2003-08-14 2009-11-25 Сефалон, Инк. Ингибиторы протеасомы и способ их применения (варианты)
EP2377868A1 (en) * 2004-03-30 2011-10-19 Millennium Pharmaceuticals, Inc. Synthesis of Bortezomib
WO2006008660A2 (en) 2004-07-20 2006-01-26 Affinium Pharmaceuticals, Inc. Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk)
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds
GB0513349D0 (en) 2005-06-29 2005-08-03 Torres Manel Non-woven fabric
EP1898899A4 (en) 2005-07-05 2009-07-29 Tufts College ALPHA PROTEIN INHIBITORS FOR FIBROBLAST ACTIVATION

Also Published As

Publication number Publication date
EP2527347A1 (en) 2012-11-28
IL242292A (en) 2017-12-31
HUS1700018I1 (hu) 2017-05-29
UA97536C2 (en) 2012-02-27
CN101772507B (zh) 2012-12-12
CA2695082A1 (en) 2009-02-12
WO2009020448A1 (en) 2009-02-12
TN2010000060A1 (en) 2011-09-26
ZA201000348B (en) 2011-03-30
NL300871I2 (nl) 2017-12-07
FR17C1011I1 (ru) 2017-05-26
ECSP10010015A (es) 2010-04-30
NZ582693A (en) 2012-01-12
CY1113386T1 (el) 2016-06-22
AU2007357338A1 (en) 2009-02-12
CY2017016I2 (el) 2017-07-12
SG10201508712QA (en) 2015-11-27
IL242291A (en) 2017-12-31
PH12014500053A1 (en) 2015-03-30
AU2007357338B2 (en) 2014-03-20
CN101772507A (zh) 2010-07-07
EP2178888B1 (en) 2012-07-04
KR101474831B1 (ko) 2014-12-19
JP2010535759A (ja) 2010-11-25
CA2695082C (en) 2015-07-28
MY161991A (en) 2017-05-31
KR101831674B1 (ko) 2018-02-23
SI2178888T1 (sl) 2012-11-30
BRPI0721905B8 (pt) 2021-05-25
PT2178888E (pt) 2012-10-04
IL242290A0 (en) 2015-11-30
CY2017016I1 (el) 2017-07-12
KR20170004031A (ko) 2017-01-10
JP5261488B2 (ja) 2013-08-14
DK2178888T3 (da) 2012-10-01
LUC00013I1 (ru) 2017-04-06
KR20150010802A (ko) 2015-01-28
BRPI0721905A2 (pt) 2014-02-25
HRP20120745T1 (hr) 2012-10-31
IL242290A (en) 2017-12-31
PL2178888T3 (pl) 2012-11-30
EP2178888A1 (en) 2010-04-28
IL242292A0 (en) 2015-11-30
EA028622B1 (ru) 2017-12-29
KR20100059811A (ko) 2010-06-04
BRPI0721905B1 (pt) 2020-11-17
ES2390606T3 (es) 2012-11-14
LUC00013I2 (ru) 2017-06-19
IL203641A (en) 2015-11-30
GEP20125599B (en) 2012-08-10
IL242291A0 (en) 2015-11-30
KR20140042932A (ko) 2014-04-07
KR20140042933A (ko) 2014-04-07
RS52435B (en) 2013-02-28
FR17C1011I2 (fr) 2018-04-27
KR20160040735A (ko) 2016-04-14
PH12014500053B1 (en) 2015-03-30
LTC2178888I2 (lt) 2018-03-12
EP3210987A1 (en) 2017-08-30
LTPA2017010I1 (lt) 2017-05-10
HK1182924A1 (zh) 2013-12-13
EA201070247A1 (ru) 2010-06-30

Similar Documents

Publication Publication Date Title
HUS1700018I1 (hu) Proteoszóma inhibitorok
HK1176601A1 (zh) 抑制劑
ZA201100898B (en) Novel inhibitors
ZA201102837B (en) Phosphodiestarase inhibitors
IL211811A0 (en) Protease inhibitors
EP2177529A4 (en) NEW DE-SECRETASE INHIBITOR
EP2222662A4 (en) INHIBITORS OF KYNURENINE AMINO TRANSFERASE
GB0817425D0 (en) Protease inhibitors
GB0707315D0 (en) Novel proteasome inhibitor
GB0714941D0 (en) Inhibitors
GB0713152D0 (en) Phosphodlesterase inhibitors
GB0707495D0 (en) Novel inhibitors
GB0707488D0 (en) Novel inhibitors
GB0707497D0 (en) Novel inhibitors
GB0704589D0 (en) Novel inhibitors
GB0707632D0 (en) Novel inhibitors
GB0707499D0 (en) Novel inhibitors
GB0707498D0 (en) Novel inhibitors
GB0707493D0 (en) Novel inhibitors
GB201019387D0 (en) Inhibitors
GB0816125D0 (en) Novel inhibitors
GB0708255D0 (en) Cysteine prtease inhibitors
GB0705212D0 (en) Protease inhibitors
GB0700369D0 (en) Protease inhibitors
GB0705213D0 (en) Protease inhibitors